Solid Biosciences Inc.
SLDB
$3.29
-$0.015-0.46%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 148.92M | 171.12M | 190.27M | 206.07M | 123.64M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.65M | 1.61M | 2.12M | 3.09M | 2.11M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.73M | 6.77M | 5.22M | 5.03M | 3.98M |
| Total Current Assets | 157.30M | 179.49M | 197.61M | 214.19M | 129.73M |
|
|
|||||
| Total Current Assets | 157.30M | 179.49M | 197.61M | 214.19M | 129.73M |
| Net Property, Plant & Equipment | 29.04M | 29.93M | 30.95M | 32.49M | 33.16M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.32M | 2.41M | 2.43M | 2.01M | 2.04M |
| Total Assets | 188.66M | 211.83M | 230.98M | 248.69M | 164.94M |
|
|
|||||
| Total Accounts Payable | 4.24M | 3.46M | 2.52M | 1.73M | 2.03M |
| Total Accrued Expenses | 19.85M | 13.23M | 9.92M | 10.33M | 10.16M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.02M | 2.77M | 2.25M | 2.19M | 2.32M |
| Total Finance Division Other Current Liabilities | 3.15M | 3.40M | -- | 92.00K | -- |
| Total Other Current Liabilities | 3.15M | 3.40M | -- | 92.00K | -- |
| Total Current Liabilities | 30.26M | 22.85M | 14.69M | 14.34M | 14.52M |
|
|
|||||
| Total Current Liabilities | 30.26M | 22.85M | 14.69M | 14.34M | 14.52M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 21.16M | 21.95M | 23.05M | 23.63M | 23.94M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 51.42M | 44.80M | 37.74M | 37.97M | 38.46M |
|
|
|||||
| Common Stock & APIC | 920.65M | 907.76M | 901.39M | 893.78M | 785.22M |
| Retained Earnings | -783.45M | -740.85M | -708.13M | -683.06M | -658.75M |
| Treasury Stock & Other | 47.00K | 116.00K | -15.00K | -4.00K | 15.00K |
| Total Common Equity | 137.25M | 167.02M | 193.25M | 210.72M | 126.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 137.25M | 167.02M | 193.25M | 210.72M | 126.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 137.25M | 167.02M | 193.25M | 210.72M | 126.48M |
|
|
|||||